Review Article

Vascular Dementia

Authors: Richard Strub, MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

  1. 1. Chui H. Vascular dementia, a new beginning: Shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin 2000; 18: 951–978.
  2. 2. Marshall J. Vascular dementias, in Whitehouse PJ (ed): Dementia. Philadelphia, F.A. Davis, 1992, pp 215–236.
  3. 3. Hachinski VC, Lassen NA, Marshall J. Multiinfarct dementia: A cause of mental deterioration in the elderly. Lancet 1974; 2: 207–210.
  4. 4. Pantoni L, Garcia JH. Pathogenesis of leukoariosis: A review. Stroke 1997; 28: 652–659.
  5. 5. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42–48.
  6. 6. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 57: 714–716.
  7. 7. deGroot JC, deLeeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam scan study. Neurology 2001; 56: 1539–1545.
  8. 8. Pohjasraara T, Mäntylä R, Ylikoski MA, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke 2000; 31: 2952–2957.
  9. 9. Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56: 1683–1689.
  10. 10. O'Sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS. Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology 2001; 57: 632–638.
  11. 11. Moser DJ, Cohen RA, Paul RH, Paulsen JS, Ott BR, Gordon NM, et al. Executive function and magnetic resonance imaging subcortical hyperintensities in vascular dementia. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 89–92.
  12. 12. Almkvist O, Backman L, Basun H, Wahlund LO. Patterns of neuropsychological performance in Alzheimer's disease and vascular dementia. Cortex 1993; 29: 661–673.
  13. 13. Wolfe N, Linn R, Babikian VL, Knoefel JE, Albert ML. Frontal systems impairment following multiple lacunar infarcts. Arch Neurol 1990; 47: 129–132.
  14. 14. Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999; 53: 670–678.
  15. 15. Albert ML. Subcortical dementia, in Katzman R, Terry RD, Bick KL (eds): Alzheimer's Disease, Senile Dementia and Related Disorders. New York, Raven Press, 1978, pp 173–180.
  16. 16. Mungas D, Jagust WS, Reed BR, Kramer JH, Weiner MW, Schuff N, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001; 57: 2229–2235.
  17. 17. Román G. Diagnosis of vascular dementia and Alzheimer's disease. Int J Clin Pract Suppl 2001; 120: 9–13.R
  18. 18. Wei X, Warfield S, Zou K, Wu Y, Li X, Guimond A, et al. Quantitative analysis of MRI white matter signal abnormalities with high reproducibility and accuracy. J Magn Reson Imaging 2002; 15: 203–209.
  19. 19. Sattel H, Forstl H, Biedert S. Senile dementia of Alzheimer type and multiinfarct dementia investigated by transcranial Doppler sonography. Dementia 1996; 7: 41–46.
  20. 20. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galanthamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomized trial. Lancet 2002; 359: 1283–1290.